The size of the radiotherapy market in the Middle East and Africa was worth USD 0.58 billion in 2023 and is estimated to be growing at a CAGR of 5.8% to reach USD 0.77 Billion by 2028.
The growing cancer patient population in the MEA region is majorly propelling the growth of the radiotherapy market in the Middle East and Africa. The growing consumption of tobacco, and alcohol and increasing adoption of an unhealthy diet, genetic issues and hormonal changes are majorly leading to the rising incidence of cancer among people. The awareness among people regarding the available diagnosis and treatment procedures to cure cancer has increased in recent years in the Middle East and Africa, which is one of the key factors behind the increased usage of radiotherapy in this region.
The growing awareness about the benefits of radiotherapy for cancer treatment is further fuelling the growth rate of the radiotherapy market in the Middle East and Africa. Radiotherapy is one of the effective treatment options for cancer and can be done as a single treatment or combined with other surgeries. The growing awareness campaigns by several healthcare organizations to provide information about the benefits of radiotherapy are contributing to the radiotherapy market growth in MEA.
The rising adoption of technological advancements in radiotherapy is promoting the radiotherapy market growth in MEA. The key market players in the MEA region are focusing on developing the devices used for radiotherapy treatment. Researchers focus on manufacturing semi-automated and fully automated radiotherapy devices with highly advanced camera lenses and wireless devices for cancer treatment and use advanced technology in manufacturing devices to help detect cancer's correct position in the body and apply radiation to kill cancer and abnormal cells. In addition, increasing training centers for radiotherapy, growing funding by governmental and non-governmental organizations in favor of radiotherapy, increasing investments by the governments for research and development, and increasing clinical trials are favoring the radiotherapy market in MEA.
The absence of qualified workers to present radiotherapy and competent alternate treatment obstructs the market's growth. The high cost of the treatment is the central issue for the market growth in this region. Lack of skilled professionals, lack of proper infrastructure in the hospital, and low awareness about radiotherapy are the other factor hampering the market growth. Increasing complications after radiotherapy also challenge the market growth. Some side effects are killing healthy cells around the abnormal cells, hair loss, fatigue, nausea, memory loss, skin change, and headache.
This research report on the Middle East and Africa radiotherapy market has been segmented and sub-segmented into the following categories:
By Equipment Type:
Geographically, the MEA accounted for a moderate share of the global market in 2022 and is anticipated to grow at a steady CAGR during the forecast period owing to the increasing adoption of radiotherapy by cancer patients. Saudi Arabia holds the major share of the MEA market due to increasing research centers for cancer therapies. Nearly 60% of cancer patients in Arab countries use radiotherapy to kill cancer cells in the human body. This research center helps develop advanced radiotherapies which reduce side effects and give positive results to cancer patients. Students in the country have also done much research to increase the accuracy of radiotherapy. Additionally, increasing lung cancer cases in Saudi Arabia also demand radiotherapy.
Increasing radiotherapy centers and hospitals in Egypt is the primary factor for the market's growth. These hospitals provide cost-effective radiotherapy for all types of cancer in the body to increase the survival rate of the patients. In addition, there is also a particular radiotherapy hospital for children in Egypt country. With increasing radiotherapy jobs and an increasing number of radiologists in the country, UAE also has a share in the market growth. In addition, many medical students are interested in taking radiotherapy courses as their career due to the increasing number of different types of cancer in the body, such as lung, kidney, cervical, and brain, etc.
KEY MARKET PLAYERS:
Companies playing an active role in the MEA radiotherapy market profiled in this report are Nordion Inc., RaySearch Laboratories AB, Ion Beam Applications SA, C. R. Bard Inc., Mevion Medical Systems Inc., Varian Medical Systems Inc., IsoRay Medical Inc., Elekta AB, Accuray Incorporated and Mitsubishi Electric Corporation.
The key drivers of the MEA radiotherapy market include an increasing incidence of cancer in the region, growing awareness about the benefits of radiation therapy, and the availability of advanced technologies for cancer treatment.
The major challenges facing the MEA radiotherapy market include the high cost of treatment, a lack of skilled professionals, and limited access to advanced technologies in some areas.
The MEA radiotherapy market is dominated by countries such as Saudi Arabia, the UAE, and Egypt. These countries have a growing number of cancer patients and are investing in advanced technologies to improve the quality of cancer care.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org